Europe Airway Management Device Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Europe Airway Management Device Market Size

• The Europe airway management device market size was valued at USD 638.73 million in 2024 and is expected to reach USD 950.91 million by 2032, at a CAGR of 5.10% during the forecast period
• The market growth is largely fueled by the growing adoption of advanced medical technologies and technological progress within healthcare infrastructure, leading to increased digitalization in both hospital and pre-hospital settings
• Furthermore, rising healthcare provider demand for efficient, safe, and integrated solutions for patient airway management is establishing advanced airway management devices as the modern standard of care. These converging factors are accelerating the uptake of Europe airway management device solutions, thereby significantly boosting the industry's growth

Europe Airway Management Device Market Analysis

• Airway management devices, crucial for ensuring and maintaining open airways in patients, are increasingly vital components of modern healthcare systems in various medical settings, including emergency care, anesthesia, and critical care, due to their enhanced patient safety, efficiency, and role in supporting essential medical procedures
• The escalating demand for airway management devices is primarily fueled by the increasing prevalence of respiratory disorders, the rising number of surgical procedures, and a growing emphasis on patient safety and effective ventilation
• Germany dominated the Europe airway management device market in 2024, driven by a mature healthcare infrastructure, widespread implementation of advanced medical equipment, and a high number of surgeries requiring airway management, particularly in cardiothoracic and neurosurgical procedures
• Turkey is expected to be the fastest growing country in the Europe airway management device market with a of CAGR of 7.5% during 2025–2032. The country is undergoing a rapid transformation in its healthcare infrastructure, spurred by government initiatives such as City Hospitals Projects and Health Transformation Program, which focus on expanding surgical capacity and intensive care units
• Anesthesia segment dominated the Europe airway management device market in 2024, due to reflecting the high volume of surgical procedures requiring effective airway management

Report Scope and Europe Airway Management Device Market Segmentation

Europe Airway Management Device Market Trends

“Advancing Clinical Efficiency Through Smart Technologies”

• A significant and accelerating trend in the Europe airway management device market is the deepening integration with artificial intelligence (AI) and advanced digital interfaces, including voice-activated controls. This fusion of technologies is significantly enhancing clinician efficiency and precision over their patient care processes
  • For instance, while still evolving, certain high-end ventilators and video laryngoscopes are beginning to incorporate voice-activated features, allowing medical professionals to adjust settings or capture images with simple verbal commands, thus maintaining sterile fields. Similarly, smart intubation guidance systems could leverage AI to provide real-time anatomical insights for safer and more efficient procedures
• AI integration in airway management devices enables features such as predictive analytics for respiratory distress, optimized ventilation parameters based on real-time patient physiology, and intelligent alerts for critical events. For instance, some next-generation ventilators could utilize AI to dynamically adapt oxygen delivery based on continuous patient feedback, or smart monitors could send intelligent alerts if unusual breathing patterns are detected. Furthermore, voice control capabilities offer clinicians the ease of hands-free operation, allowing them to make critical adjustments, access data, or document findings without diverting their hands from patient care
• The seamless integration of advanced airway management devices with electronic health records (EHR) systems and broader patient monitoring platforms facilitates centralized control over various aspects of the connected clinical environment. Through a single interface, users can manage device settings, access patient historical data, and coordinate with other life support systems, creating a unified and automated patient care experience
• This trend towards more intelligent, intuitive, and interconnected airway management systems is fundamentally reshaping clinical workflows and expectations for patient safety and efficiency. Consequently, leading medical device companies are developing AI-enabled solutions with features such as automated parameter adjustments based on patient condition and voice control compatibility for critical care environments
• The demand for airway management devices that offer seamless AI and voice control integration is growing rapidly across hospitals, emergency medical services, and critical care units in Europe, as healthcare providers increasingly prioritize operational efficiency, enhanced patient outcomes, and advanced clinical decision support

Europe Airway Management Device Market Dynamics

Driver

“Growing Need Due to Rising Respiratory Disorders and Advanced Clinical Practices”

• The increasing prevalence of respiratory disorders, a growing elderly population, and the accelerating number of surgical procedures are significant drivers for the heightened demand for airway management devices in Europe
  • For instance, in 2024, advancements in integrated video laryngoscopes focusing on improved visualization and safer intubation procedures were launched by key medical device companies, further propelling the Europe Airway Management Device industry growth in the forecast period. Such innovations address critical needs in emergency medicine and operating theaters
• As healthcare professionals become more aware of the importance of early and effective airway intervention and seek enhanced patient safety, advanced airway management devices offer features such as superior visualization, precise ventilation control, and reduced risk of complications, providing a compelling upgrade over traditional methods
• Furthermore, the growing popularity of digital health solutions and the desire for integrated clinical environments are making advanced airway management devices an integral component of modern patient care systems, offering seamless connectivity with patient monitors and electronic health records
• The convenience of improved first-pass intubation success rates, enhanced patient comfort, and the ability to manage critical care scenarios with greater precision are key factors propelling the adoption of advanced airway management devices across hospitals, clinics, and emergency services. The trend towards specialized training in difficult airway management and the increasing availability of user-friendly devices further contribute to market growth

Restraint/Challenge

“Concerns Regarding High Initial Costs and Training Requirements”

• Concerns surrounding the high initial investment required for advanced airway management devices, such as video laryngoscopes and sophisticated ventilators, pose a significant challenge to broader market penetration in Europe. These devices, with their complex optics, digital components, and precision engineering, represent a substantial capital expenditure for healthcare institutions
  • For instance, the cost of acquiring state-of-the-art video laryngoscopes or advanced automated ventilation systems can be a barrier for smaller clinics or institutions with budget constraints, making them hesitant to upgrade from more basic or reusable equipment
• Addressing these challenges through robust clinical training programs, clear guidelines for effective device use, and the development of more cost-effective yet high-performing Europe airway management device options is crucial for wider market adoption. While basic devices remain affordable, the perceived premium for advanced features can still hinder widespread uptake, especially for those who may not see an immediate return on investment for all advanced functionalities
• While prices are gradually decreasing for some device categories, the perceived premium for advanced medical technology can still hinder widespread adoption, especially for those who do not see an immediate need for the advanced features offered
• Overcoming these challenges through enhanced training and simulation-based education, the development of more affordable and durable device options, and potentially favorable reimbursement policies will be vital for sustained market growth

Europe Airway Management Device Market Scope

The Europe airway management device market is segmented into several notable segments based on product type, patient type, application, end user, and distribution channel.

• By Product Type

On the basis of product type, the Europe airway management device market is segmented into supraglottic airway management devices, infraglottic airway management devices, laryngoscopes, ventilators, resuscitators, cricothyrotomy kits, and other airway management devices. The supraglottic airway management devices segment dominated the market in 2024 with a market share of 33.10%, driven by its rising demand due to reduced risk of complications and ease of use in various clinical scenarios.

The laryngoscopes segment is expected to be the fastest-growing segment from 2025 to 2032 with a growth rate of 8.91%, primarily due to ongoing technological advancements, particularly in video laryngoscopy, and the increasing complexity of airway management procedures.

• By Patient Type

On the basis of patient type, the Europe airway management device market is segmented into adult patients and pediatric/neonatal patients. The adult patients segment dominated the Europe airway management device market in 2024 with a market share of 67.08%, due to the rising prevalence of respiratory disorders and the higher volume of surgical procedures among the adult population.

The adult patients segment is also expected to be the fastest-growing segment in the Europe airway management devices market with a growth rate of 8.79% during the forecast period of 2025-2032, reflecting the increasing healthcare needs of the aging population.

• By Application

On the basis of application, the Europe airway management device market is segmented into anesthesia, emergency medicine, and others. The anesthesia segment dominated in 2024 with a market share of 49.95%, as these devices are indispensable for maintaining an open airway during surgical procedures requiring anesthesia.

The emergency medicine segment is expected to witness the fastest CAGR from 2025 to 2032, due to the increasing number of patients requiring prolonged ventilation and critical airway support.

• By End User

On the basis of end user, the Europe airway management device market is segmented into hospitals, speciality clinics, ambulatory care settings, clinics, homecare settings, cardiac centers, and others. The hospitals segment dominated the Europe airway management device market in 2024, driven by the high volume of surgical procedures, emergency cases, and critical care admissions requiring comprehensive airway management.

The hospitals segment is expected to be the fastest-growing segment in the Europe airway management devices market from 2025 to 2032, as they continue to be the primary centers for complex medical interventions.

• By Distribution Channel

On the basis of distribution channel, the Europe airway management device market is segmented into direct tender, retail sales, and online sales. The direct tender segment dominated the market share of 47.89%, as large hospitals and government institutions often procure devices through direct tenders to ensure bulk purchasing and quality control. Online Sales segment is expected to witness the fastest CAGR from 2025 to 2032 due to convenience and accessibility.

Europe Airway Management Device Market Regional Analysis

• Europe helds a significant position in the Europe airway management device market, with a market value of USD 638.73 Million in 2024. This strong presence is driven by a well-developed healthcare infrastructure, high awareness regarding advanced airway management equipment, and proactive government initiatives aimed at improving healthcare services and infrastructure. The region also benefits from a high prevalence of respiratory disorders and a large elderly population, both contributing to a sustained demand for these devices
• Other key countries contributing significantly to the European market include the U.K., France, Italy, and Spain. These nations are experiencing substantial growth driven by factors such as increasing respiratory disease incidence, robust healthcare facilities, and a growing number of surgical procedures that necessitate effective airway management
• The widespread adoption of airway management devices in Europe is further supported by high healthcare expenditures, a technologically advanced medical community, and a growing preference for enhanced patient safety and precise interventions. These factors collectively establish advanced airway management devices as essential tools for healthcare professionals across the European Union and surrounding countries

Germany Europe Airway Management Device Market Insight

The Germany airway management device market captured the largest revenue share of 21.5% in 2024. The market is forecast to grow at a CAGR of 6.3% during 2025–2032. This growth is driven by a mature healthcare infrastructure, widespread implementation of advanced medical equipment, and a high number of surgeries requiring airway management, particularly in cardiothoracic and neurosurgical procedures. Germany’s emphasis on digitizing hospital operations and improving intensive care capabilities is also encouraging the adoption of video laryngoscopes, endotracheal tubes, and supraglottic airway devices.

U.K. Europe Airway Management Device Market Insight

The U.K airway management device market is anticipated to grow at a noteworthy CAGR during the forecast period. Market expansion is underpinned by rising respiratory ailments, enhanced adoption of non-invasive ventilation in primary care settings, and the National Health Service's focus on incorporating AI-integrated and sensor-based airway management systems. Increased training and simulation programs are also supporting the usage of technologically advanced devices in clinical education and hospital deployment.

Turkey Europe Airway Management Device Market Insight

The Turkey airway management device market is poised to grow at the fastest CAGR of 7.5% during the forecast period of 2025 to 2032. The country is undergoing a rapid transformation in its healthcare infrastructure, spurred by government initiatives such as City Hospitals Projects and Health Transformation Program, which focus on expanding surgical capacity and intensive care units.

Increasing awareness about respiratory complications, especially due to environmental factors and smoking-related illnesses, is driving the demand for airway management in both preventive and emergency care settings. Moreover, growing collaboration between

Europe Airway Management Device Market Share

The Europe airway management device industry is primarily led by well-established companies, including:

• Medtronic (Ireland)
• Teleflex Incorporated (U.S.)
• ICU Medical, Inc. (U.S.)
• Ambu A/S (Denmark)
• Fisher & Paykel Healthcare Limited (New Zealand)
• Nihon Kohden Corporation (Japan)
• Convatec Inc. (U.K.)
• Hollister Incorporated (U.S.)
• Intersurgical Ltd (U.K.)
• VYAIRE (U.S.)
• KARL STORZ SE & Co. KG (Germany)
• Bactiguard AB (Sweden)
• Armstrong Medical Inc. (U.K.)
• Flexicare (Group) Limited (U.K.)
• P3 Medical Ltd. (U.K.)
• AdvaCare Pharma (U.S.)
• VBM Medizintechnik GmbH (Germany)
• Anaesthetics India Private Limited (India)

Latest Developments in Europe Airway Management Device Market

• In May 2024, Medtronic plc announced the launch of its latest Shiley Flexible Tracheostomy Tube with TaperGuard cuff across European markets. Designed to reduce microaspiration and improve patient comfort, the launch emphasizes Medtronic's commitment to enhancing respiratory care in intensive care and long-term ventilation settings. This expansion aligns with the company's strategy to innovate patient-centric airway solutions and strengthen its leadership in the European critical care space
• In April 2024, Ambu A/S received CE mark approval for its new Ambu VivaSight 2 DLT, a second-generation single-use bronchoscope with an integrated camera for real-time visualization during thoracic surgeries. The advanced design enhances airway control and surgical efficiency, particularly in minimally invasive procedures. The product is expected to gain significant traction across European surgical centers focused on infection prevention and procedural precision
• In March 2024, Fisher & Paykel Healthcare introduced its Optiflow 3 Nasal High Flow System in select European countries, tailored for adult and pediatric patients requiring non-invasive respiratory support. The device is engineered to optimize oxygen therapy and reduce escalation to invasive ventilation, aligning with Europe’s growing preference for non-invasive airway management techniques in both hospitals and homecare
• In February 2024, Teleflex Incorporated announced the expansion of its Rusch and LMA airway management product lines in Europe, targeting emergency response and prehospital care segments. The strategic rollout includes enhanced supraglottic airway devices and intubation accessories that aim to improve clinical outcomes in out-of-hospital cardiac arrest (OHCA) and trauma cases, reinforcing Teleflex’s focus on life-saving interventions
• In January 2024, Intersurgical Ltd launched its new range of i-gel Plus supraglottic airway devices in the U.K. and Germany. Designed for improved fit and ease of insertion, the i-gel Plus offers clinicians a more intuitive solution during anesthesia and emergency airway management. The launch supports Intersurgical's commitment to innovation and reinforces its reputation as a leading provider of airway products in the European surgical and emergency care markets
• In December 2023, ICU Medical, Inc. unveiled its advanced ventilator-compatible closed suction systems across key European hospitals. These systems are developed to maintain continuous ventilation while performing airway suctioning, improving patient safety in ICU settings. The rollout complements ICU Medical’s broader focus on infection control and critical care efficiency
• In November 2023, Vyaire Medical partnered with several leading hospitals in France and Spain to pilot its AVEA Comprehensive Airway Management Platform, an AI-enhanced solution for respiratory monitoring and ventilator weaning. This marks a key step in the integration of smart technologies within the European airway care ecosystem and positions Vyaire as a frontrunner in digital respiratory health

SKU-51757